170 related articles for article (PubMed ID: 3315449)
1. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
Mayer O; Polívková H
Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
[TBL] [Abstract][Full Text] [Related]
2. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
[TBL] [Abstract][Full Text] [Related]
3. [Minimal useful dose of guanfacine in patients with essential hypertension].
Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M
Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
[No Abstract] [Full Text] [Related]
4. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
5. Guanfacine in the treatment of hypertensives with a pronounced response to exercise and diabetes mellitus.
Dvorák I; Podrouzková B; Kocourková J; Kubesová H; Spác J; Nĕmcová H; Blaha M
Cor Vasa; 1987; 29(4 Suppl 1):30-6. PubMed ID: 3315448
[TBL] [Abstract][Full Text] [Related]
6. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1981 Jun; 19(6):279-87. PubMed ID: 7030975
[TBL] [Abstract][Full Text] [Related]
7. [Estulic in the long-term treatment of hypertension].
Rhomberg F
Schweiz Med Wochenschr; 1980 Dec; 110(50):1922-4. PubMed ID: 6782668
[TBL] [Abstract][Full Text] [Related]
8. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
Board AW; Perry VP; Shepperson BE; Nyman CE; Carchman SH
Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
[TBL] [Abstract][Full Text] [Related]
9. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
10. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of arterial hypertension with a single daily dose of guanfacine].
Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
[No Abstract] [Full Text] [Related]
12. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
Jerie P; Lasance A
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):170-4. PubMed ID: 6370876
[TBL] [Abstract][Full Text] [Related]
13. [A new antihypertensive agent used in a clinical setting].
Wetzels E; Raschig A; Kaiser HJ
Med Klin; 1980 Sep; 75(19):688-92. PubMed ID: 7001207
[TBL] [Abstract][Full Text] [Related]
14. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical experience with guanfacine.
Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
[TBL] [Abstract][Full Text] [Related]
16. Examination of the antihypertensive action of long-term estulic (Egis-Sandoz) treatment.
Zeher M; Antal L; Azad AQ; Szegedi G
Ther Hung; 1988; 36(3):103-8. PubMed ID: 3074520
[No Abstract] [Full Text] [Related]
17. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
18. [Circadian changes in arterial blood pressure and hemodynamics and the morphofunctional state of the myocardium in patients with hypertension during long-term treatment with estulic].
Komarov FI; Ol'binskaia LI; Iamshchikov SN
Klin Med (Mosk); 1990 Feb; 68(2):58-61. PubMed ID: 2186218
[TBL] [Abstract][Full Text] [Related]
19. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
[TBL] [Abstract][Full Text] [Related]
20. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
Lifshits NL; Ermolenko VM; Rozhdestvenskaia TM; Tatsievskiĭ VA; Panasiuk VV
Ter Arkh; 1984; 56(7):66-9. PubMed ID: 6385325
[No Abstract] [Full Text] [Related]
[Next] [New Search]